Article ID Journal Published Year Pages File Type
2159408 Radiotherapy and Oncology 2010 6 Pages PDF
Abstract

PurposeTo quantify the influence of fluctuating blood glucose level (BGLs) and the timing of PET acquisition on PET-based predictions of the pathological treatment response in rectal cancer.Material and methodsThirty patients, diagnosed with locally advanced-rectal-cancer (LARC), were included in this prospective study. Sequential FDG–PET–CT investigations were performed at four time points during and after pre-operative radiochemotherapy (RCT). All PET-data were normalized for the BGL measured shortly before FDG injection. The metabolic treatment response of the tumor was correlated with the pathological treatment response.ResultsDuring RCT, strong intra-patient BGL-fluctuations were observed, ranging from −38.7 to 95.6%. BGL-normalization of the SUVs revealed differences ranging from −54.7 to 34.7% (p < 0.001). Also, a SUVmax time-dependency of 1.30 ± 0.66 every 10 min (range: 0.39–2.58) was found during the first 60 min of acquisition. When correlating the percent reduction of SUVmax after 2 weeks of RCT with the pathological treatment response, a significant increase (p = 0.027) in the area under the curve of ROC-curve analysis was found when normalizing the PET-data for the measured BGLs, indicating an increase of the predictive strength.ConclusionsThis study strongly underlines the necessity of BGL-normalization of PET-data and a precise time-management between FDG injection and the start of PET acquisition when using sequential FDG–PET–CT imaging for the prediction of pathological treatment response.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , ,